Is QuickClot (zeolite hemostatic agent) still used in medical practice?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

QuickClot Use in Current Medical Practice

The original zeolite-based QuickClot is no longer recommended due to significant safety concerns, but the newer kaolin-based QuickClot Combat Gauze remains a widely used and recommended hemostatic agent in both military and civilian settings. 1

Evolution of QuickClot Products

The original zeolite-based QuickClot caused severe complications:

  • Burns and tissue damage occurred from exothermic reactions reaching temperatures of 93.3°C at the tissue interface, with one documented case requiring skin grafting 2, 3
  • Patients experienced mild to severe pain and discomfort from the heat generated during application 2
  • Foreign body reactions and scar formation complicated intracorporeal use 2
  • Despite these issues, the zeolite version showed 92% efficacy in controlling hemorrhage when applied correctly 2

Current Recommendations for Hemostatic Dressings

Modern hemostatic agents (including newer QuickClot formulations) are first-line interventions when standard hemorrhage control fails:

  • Apply hemostatic dressings when direct manual pressure for 5-10 minutes does not achieve hemostasis, particularly for severe arterial bleeding in compressible locations 1
  • The American Heart Association reports a 90.8% success rate in achieving hemostasis with current hemostatic dressings 1
  • 73% of cases achieve bleeding cessation in under 3 minutes with proper application 1

Proper Application Technique

The critical steps for effectiveness include:

  • Pack the dressing directly into the wound at the source of bleeding and maintain firm pressure for a minimum of 3 minutes 1
  • Do not repeatedly lift to check for bleeding cessation during the initial pressure application 1
  • Complications occur in only 3% of cases with proper technique 1

Clinical Context and Agent Selection

Current guidelines recommend selecting hemostatic agents based on bleeding characteristics:

  • Mineral-based agents are recommended for external bleeding in prehospital settings 1
  • Chitosan-based agents (like Axiostat) are recommended for venous and moderate arterial bleeding, particularly when access to the bleeding site is difficult 4
  • Collagen-based agents directly trigger platelet aggregation and are effective when other hemostatic mechanisms are compromised 5

Military and Civilian Experience

QuikClot Combat Gauze (the kaolin-based version) has demonstrated effectiveness:

  • 79-93% success rates reported in military field use without the thermal complications of the original zeolite version 6, 7
  • Successfully used in 30 civilian prehospital cases with 22 complete cessations of bleeding and no reported side effects 6
  • The US military recommends QuikClot Combat Gauze as the first-line hemostatic agent for severe hemorrhage 8

References

Guideline

Hemostatic Dressing Guidelines for Severe External Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Axiostat for Controlling Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hemostatic Agents in Gynecologic Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hemostatic dressings in civil prehospital practice: 30 uses of QuikClot Combat Gauze.

European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.